Article

Speaker suggests ways to reduce post-LASIK ectasia

"Reported cases of ectasia have been diagnosed up to 4 years after LASIK," said R. Doyle Stulting, MD, PhD, during a symposium on ectatic diseases in corneal and refractive surgery.

"Reported cases of ectasia have been diagnosed up to 4 years after LASIK," said R. Doyle Stulting, MD, PhD, during a symposium on ectatic diseases in corneal and refractive surgery.

"Pathology suggests cell loss and abnormalities of keratocytes, leaving us to wonder whether defective keratocyte metabolism could make ectasia more likely and to wonder whether mitomycin C might increase the long-term risk of ectasia," said Dr. Stulting, a professor of ophthalmology and director of the cornea, external diseases and refractive surgery section at the Emory Eye Center, Atlanta.

To reduce the incidence of post-LASIK ectasia, he said, patients should be screened carefully based on probable and possible risk factors such as forme fruste keratoconus, low corneal thickness and residual stromal bed, young age, changing refraction, and eye rubbing.

"Increased communication amongst refractive surgeons, scientifically based multifactorial scales for evaluating risks, and prospective trials for borderline cases are indicated," he said. "We need basic investigations of keratocyte function and intervention for eyes with abnormal elasticity."

Dr. Stulting is the project director for an ectasia registry, ectasiaregistry.com, that is about to be launched through a collaboration of the American Society of Cataract and Refractive Surgery; Clinical Research Consultants Inc.; and DSG Inc. Dr. Stulting, the chairman of the ASCRS Refractive Committee, encouraged symposium attendees to begin entering data when possible to help identify current patients at risk and also to identify investigators who might be willing to participate in prospective clinical trials in the future.

Dr. Stulting has no financial interest in any products or companies related to his talk.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.